VEGFA and microtia: The results of this study show that the development of MA increases as the follow-up period increases in highly myopic eyes with mCNV treated with intravitreal anti-VEGF injection, and its occurrence was estimated to be 24.5% at 3 years and 37.3% at 5 years after initial treatment.